Clinical trials
Completed Phase 1/2 Anemia, Refractory, with Excess of Blasts trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 1 |
| 2002 | 3 |
| 2004 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2013 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 3 |
| Fred Hutchinson Cancer Center | 2 |
| Case Comprehensive Cancer Center | 1 |
| Cellerant Therapeutics | 1 |
| Drexel University College of Medicine | 1 |
| Duke University | 1 |
| Groupe Francophone des Myelodysplasies | 1 |
| Masonic Cancer Center, University of Minnesota | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Mikkael Sekeres MD | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Refractory, with Excess of Blasts | 18 |
| Leukemia, Myelomonocytic, Chronic | 10 |
| Myelodysplastic Syndromes | 10 |
| Leukemia | 9 |
| Leukemia, Myeloid, Acute | 9 |
| Myeloproliferative Disorders | 5 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Anemia, Refractory | 4 |
| Congenital Abnormalities | 4 |
| Blast Crisis | 3 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.